Surface Oncology : Coherus to Acquire Surface Oncology - Form 8-K
Coherus to Acquire Surface Oncology - Surface acquisition and potential toripalimab approval will transform Coherus into an I-O company with multiple... | June 16, 2023
Source: marketscreener.com